Aspergillus Tracheobronchitis in a Mild Immunocompromised Host

Aspergillus tracheobronchitis is a form of invasive pulmonary aspergillosis in which the Aspergillus infection is limited predominantly to the tracheobronchial tree. It occurs primarily in severely immunocompromised patients such as lung transplant recipients. Here, we report a case of Aspergillus tracheobronchitis in a 42-year-old man with diabetes mellitus, who presented with intractable cough, lack of expectoration of sputum, and chest discomfort. The patient did not respond to conventional treatment with antibiotics and antitussive agents, and he underwent bronchoscopy that showed multiple, discrete, gelatinous whitish plaques mainly involving the trachea and the left bronchus. On the basis of the bronchoscopic and microbiologic findings, we made the diagnosis of Aspergillus tracheobronchitis and initiated antifungal therapy. He showed gradual improvement in his symptoms and continued taking oral itraconazole for 6 months. Physicians should consider Aspergillus tracheobronchitis as a probable diagnosis in immunocompromised patients presenting with atypical respiratory symptoms and should try to establish a prompt diagnosis.

keywords: Aspergillosis, Allergic Bronchopulmonary, Itraconazole, Bronchoscopy

Reference

1. Kemper CA, Hostetler JS, Follansbee SE, Ruane P, Covington D, Leong SS, et al. Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS. Clin Infect Dis 1993;17:344-52.

2. Wheaton SW. Case primarily of tubercle, in which a fungus (Aspergillus ) grew in the bronchi and lung, simulating actinomycosis. Trans Pathol Soc Lond 1890;41:34-7.

3. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002;121:1988-99.

4. Boots RJ, Paterson DL, Allworth AM, Faoagali JL. Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF. Thorax 1999;54:1047-9.

5. Franco J, Munoz C, Vila B, Marin J. Pseudomembranous invasive tracheobronchial aspergillosis. Thorax 2004;59:452.

6. Lee SE, Jun EJ, Song JH, Shin JW, Kim JY, Park IW, et al. A case of pseudomembranous necrotizing bronchial aspergillosis in an old age host. Tuberc Respir Dis 2007;63:278-82.

7. Chang SM, Kuo HT, Lin FJ, Tzen CY, Sheu CY. Pseudomembranous tracheobronchitis caused by Aspergillus in immunocompromised patients. Scand J Infect Dis 2005;37:937-42.

8. Wu N, Huang Y, Li Q, Bai C, Huang HD, Yao XP. Isolated invasive Aspergillus tracheobronchitis: a clinical study of 19 cases. Clin Microbiol Infect 2010;16:689-95.

9. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev 2011;20:156-74.

10.

10. Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006;173:707-17.

11.

11. Tasci S, Glasmacher A, Lentini S, Tschubel K, Ewig S, Molitor E, et al. Pseudomembranous and obstructive Aspergillus tracheobronchitis: optimal diagnostic strategy and outcome. Mycoses 2006;49:37-42.

12.

12. Kramer MR, Denning DW, Marshall SE, Ross DJ, Berry G, Lewiston NJ, et al. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis 1991;144(3 Pt 1):552-6.

13.

13. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-60.

바로가기메뉴

Article Contents

Vol.77 No.5

Aspergillus Tracheobronchitis in a Mild Immunocompromised Host

Abstract

Reference

Tuberculosis & Respiratory Diseases